1-6 of 6
Konstantinos Kantartzis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

Stephanie Kullmann, Julia Hummel, Robert Wagner, Corinna Dannecker, Andreas Vosseler, Louise Fritsche, Ralf Veit, Konstantinos Kantartzis, Jürgen Machann, Andreas L. Birkenfeld, Norbert Stefan, Hans-Ulrich Häring, Andreas Peter, Hubert Preissl, Andreas Fritsche, Martin Heni
Journal: Diabetes Care
Diabetes Care 2022;45(2):398–406
https://doi.org/10.2337/dc21-1136
Published: 29 October 2021
View article titled, Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Open the PDF for Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial in another window
Journal Articles

Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

Sabine Kahl, Sofiya Gancheva, Klaus Straßburger, Christian Herder, Jürgen Machann, Hisayuki Katsuyama, Stefan Kabisch, Elena Henkel, Stefan Kopf, Merit Lagerpusch, Konstantinos Kantartzis, Yuliya Kupriyanova, Daniel Markgraf, Theresa van Gemert, Birgit Knebel, Martin F. Wolkersdorfer, Oliver Kuss, Jong-Hee Hwang, Stefan R. Bornstein, Christian Kasperk, Norbert Stefan, Andreas Pfeiffer, Andreas L. Birkenfeld, Michael Roden
Journal: Diabetes Care
Diabetes Care 2020;43(2):298–305
https://doi.org/10.2337/dc19-0641
Published: 20 September 2019
View article titled, Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
Open the PDF for Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver

Rainer Lehmann, PHD, Holger Franken, PHD, Sascha Dammeier, PHD, Lars Rosenbaum, PHD, Konstantinos Kantartzis, MD, Andreas Peter, MD, Andreas Zell, PHD, Patrick Adam, MD, Jia Li, PHD, Guowang Xu, PHD, Alfred Königsrainer, MD, Jürgen Machann, PHD, Fritz Schick, MD, Martin Hrabé de Angelis, PHD, Matthias Schwab, MD, Harald Staiger, PHD, Erwin Schleicher, PHD, Amalia Gastaldelli, PHD, Andreas Fritsche, MD, Hans-Ulrich Häring, MD, Norbert Stefan, MD
Journal: Diabetes Care
Diabetes Care 2013;36(8):2331–2338
https://doi.org/10.2337/dc12-1760
Published: 11 July 2013
View article titled, Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver
Open the PDF for Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver in another window
Includes: Supplementary data
Journal Articles

Circulating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans

Norbert Stefan, MD, Konstantinos Kantartzis, MD, Nora Celebi, MD, Harald Staiger, PHD, Jürgen Machann, PHD, Fritz Schick, MD, PHD, Alexander Cegan, PHD, Michaela Elcnerova, PHD, Erwin Schleicher, PHD, Andreas Fritsche, MD, Hans-Ulrich Häring, MD
Journal: Diabetes Care
Diabetes Care 2010;33(2):405–407
https://doi.org/10.2337/dc09-0544
Published: 11 November 2009
View article titled, Circulating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans
Open the PDF for Circulating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans in another window
Includes: Supplementary data
Journal Articles

Fatty Liver Is Independently Associated With Alterations in Circulating HDL2 and HDL3 Subfractions

Konstantinos Kantartzis, MD, Kilian Rittig, MD, Alexander Cegan, PHD, Jürgen Machann, PHD, Fritz Schick, PHD, Bernd Balletshofer, MD, Andreas Fritsche, MD, Erwin Schleicher, PHD, Hans-Ulrich Häring, MD, Norbert Stefan, MD
Journal: Diabetes Care
Diabetes Care 2008;31(2):366–368
https://doi.org/10.2337/dc07-1558
Published: 01 February 2008
View article titled, Fatty Liver Is Independently Associated With Alterations in Circulating HDL2 and HDL3 Subfractions
Open the PDF for Fatty Liver Is Independently Associated With Alterations in Circulating HDL2 and HDL3 Subfractions in another window
Journal Articles

The −8503 G/A Polymorphism of the Adiponectin Receptor 1 Gene Is Associated With Insulin Sensitivity Dependent on Adiposity

Konstantinos Kantartzis, MD, Andreas Fritsche, MD, Fausto Machicao, PHD, Hans-Ulrich Häring, MD, Norbert Stefan, MD
Journal: Diabetes Care
Diabetes Care 2006;29(2):464
https://doi.org/10.2337/diacare.29.02.06.dc05-2020
Published: 01 February 2006
View article titled, The −8503 G/A Polymorphism of the Adiponectin Receptor 1 Gene Is Associated With Insulin Sensitivity Dependent on Adiposity
Open the PDF for The −8503 G/A Polymorphism of the Adiponectin Receptor 1 Gene Is Associated With Insulin Sensitivity Dependent on Adiposity in another window